Hathway’s technology uses natural epigenetic processes to dial gene activity up or down, rather than rewriting the genetic ...

Pelthos Therapeutics, a Durham-based wholly owned subsidiary of Ligand Pharmaceuticals (Nasdaq: LGND), is combining with ...